STUDY TO INVESTIGATE THE ANXIOLYTIC EFFECT OF RUBIA CORDIFOLIA LINN IN MICE
DOI:
https://doi.org/10.22159/ijcpr.2025v17i6.7072Keywords:
Rubia Cordifolia, Anxiety, Locomotors activity, Plasma corticosterone, Elevated zero maze and mirrored chamberAbstract
Objective: To evaluate anxiolytic activity of extracts of Rubia cordifolia in albino mice by using Actophotometer (locomotor activity), Elevated Zero maze, Mirrored Chamber and biochemical estimation like estimation of plasma corticosterone levels.
Methods: Healthy, Swiss Albino mice weighing 20-35 g and aged 6-8 w were maintained under standard laboratory conditions with controlled temperature (25±2 °C), humidity (40±10 %) and 12 h light and dark cycles each. The animals were fed with standards rodent pellet diet and water ad libitum. Rubia cordifolia extract will be administered p. o.. to mice daily in two different doses (300 and 600 mg/kg/p. o.) for 14 d. All the animals will be evaluated for behavioral parameters, i. e. Actophotometer (locomotor activity), Elevated Zero maze, Mirrored Chamber and biochemical estimation like estimation of plasma corticosterone levels will be performed.
Results: In the present study, we have undertaken the anxiolytic activity of extracts of Rubia cordifolia in Swiss albino mice, at the dose of (300 and 600 mg/kg/p. o.) with oral administration respectively.
Conclusion: In conclusion extracts of Rubia cordifolia have shown significant results as anxiolytic activity using locomotor activity), Elevated Zero maze, Mirrored Chamber.
Downloads
References
1. Bleakley S, Maguire T. Anxiety disorders: clinical features and diagnosis. Pharm J. 2013;5:281.
2. Soodan S, Arya A. Understanding the pathophysiology and management of the anxiety disorders. Hum J Rev Artic. 2015;4:251-78.
3. Sahib S, Alexander B, Michale E, Jason S. Current diagnosis and treatment of anxiety disorders. PT. 2013;38(1):30-57. PMID 23599668.
4. Neil A, Kitchen K, Danielle B. Anxiety disorder: an information guide. Vol. 39. Toronto: Centre for Addiction and Mental Health; 2011. p. 1-37.
5. Lepine JP. The epidemiology of anxiety disorders: prevalence and societal costs. J Clin Psychiatry. 2002;63 Suppl 14:4-8. PMID 12562112.
6. Cannistraro PA, Rauch SL. Neural circuitry of anxiety: evidence from structural and functional neuroimaging studies. Psychopharmacol Bull. 2003;37(4):8-25. PMID 15131515.
7. Arikian SR, Gorman JM. A review of the diagnosis pharmacologic treatment and economic aspects of anxiety disorders. Prim Care Companion J Clin Psychiatry. 2001;3(3):110-7. doi: 10.4088/pcc.v03n0302, PMID 15014608.
8. Justin M, Sanjay J, Jack M. Molecular targets in treatment of anxiety. Biol Psychiatry. 2002 Nov 15;52(10):1008-38. doi: 10.1016/S0006-3223(02)01672-4.
9. Zeind CS, Carvalho MG, Cheng JW, Zaiken K, LaPointe T. Applied therapeutics: the clinical use of drugs. Lippincott Williams & Wilkins; 2023 Jan 6.
10. Wang HR, Woo YS, Bahk WM. Caffeine induced psychiatric manifestations: a review. Int Clin Psychopharmacol. 2015 Jul 1;30(4):179-82. doi: 10.1097/YIC.0000000000000076, PMID 25856116.
11. Indian Materia Medica. K. M. Nadkarni. Vol. 1. Bombay: Popular Prakashan; 2007. p. 1‑37.
12. Kirtikar KR, Basu BD. Indian medicinal plants. 2nd ed. Bhuwaneswari Asrama; 1918.
13. Arikian SR, Gorman JM. A review of the diagnosis pharmacologic treatment and economic aspects of anxiety disorders. Prim Care Companion J Clin Psychiatry. 2001;3(3):110-7. doi: 10.4088/pcc.v03n0302, PMID 15014608.
14. Chitra V, Pavan Kumar K. Neuroprotective studies of Rubia cordifolia Linn. On β-amyloid induced cognitive dysfunction in mice. Int J Pharm Tech Res. 2009 Oct;1(4):1000-9.
15. Kulkarni SK, Dandiya PC. Influence of intraventricular administration of norepinephrine dopamine and 5-hydroxytryptamine on motor activity of rats. Indian J Med Res. 1975;63(3):462-8. PMID 1213741.
16. Shepherd JK, Grewal SS, Fletcher A, Bill DJ, Dourish CT. Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety. Psychopharmacology. 1994 Sep;116(1):56-64. doi: 10.1007/BF02244871, PMID 7862931.
17. Reddy DS, Kulkarni SK. Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res. 1997;752(1-2):61-71. doi: 10.1016/s0006-8993(96)01447-3, PMID 9106441.
Published
How to Cite
Issue
Section
Copyright (c) 2025 ANKUSH CHAUHAN, AJEET PAL SINGH, AMAR PAL SINGH
This work is licensed under a Creative Commons Attribution 4.0 International License.
